ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,930 | -23.2% | 29,427 | -32.9% | 0.00% | – |
| Q2 2023 | $118,457 | -33.1% | 43,873 | -26.5% | 0.00% | – |
| Q1 2023 | $177,000 | +804445.5% | 59,706 | +582.3% | 0.00% | – |
| Q4 2022 | $22 | -100.0% | 8,751 | -88.1% | 0.00% | – |
| Q3 2022 | $134,000 | -84.8% | 73,668 | -73.7% | 0.00% | – |
| Q2 2022 | $882,000 | +86.1% | 279,725 | +264.5% | 0.00% | – |
| Q1 2022 | $474,000 | +134.7% | 76,750 | +440.8% | 0.00% | – |
| Q4 2021 | $202,000 | +80.4% | 14,192 | +1.4% | 0.00% | – |
| Q3 2021 | $112,000 | +148.9% | 13,993 | +787.9% | 0.00% | – |
| Q2 2021 | $45,000 | +25.0% | 1,576 | +27.4% | 0.00% | – |
| Q1 2021 | $36,000 | +157.1% | 1,237 | +7.4% | 0.00% | – |
| Q4 2020 | $14,000 | -58.8% | 1,152 | -76.6% | 0.00% | – |
| Q3 2020 | $34,000 | – | 4,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |